by Sabrina | Jul 1, 2025 | News
Nicolás Tambucho, CEO of Guska; Carlos Palma, CEO of B4-RNA; Dayana Benchoam, COO of Locbio; and Juan Gandioli, biotechnology engineer at Guska, participated in the BIO International Convention, a flagship global event in the biotechnology industry held in Boston. “In...
by Sabrina | May 16, 2025 | News
Guska, one of the startups in the LAB+ portfolio, has announced the addition of Antonio Bordería as Senior Business Advisor. Bordería is a former researcher at the Institut Pasteur in Paris, holds a PhD in molecular biology, and currently serves as Vice President at a...
by Sabrina | May 15, 2025 | News
Felipe Trajtenberg and Dayana Benchoam, from the startup Locbio, attended SynBioBeta (The Global Synthetic Biology Conference), which was held in Silicon Valley. In addition, Trajtenberg was a panelist on “How Latin America Is Building Biotech Power‑Hubs,” alongside...
by Sabrina | May 10, 2025 | News
Five of the 52 startups that applied to LAB+’s second international call pitched their projects to the Investment Committee in early May. This committee provides an opportunity for investors and LAB+ staff to learn more about the projects and ultimately decide which...
by Sabrina | May 8, 2025 | News
Agustín Correa, co-founder of the startup Scaffold Biotech, presented the results of the tick vaccine they are developing at a working breakfast attended by Uruguay’s President, Yamandú Orsi, and other national authorities. Correa emphasized that the vaccine...
by Sabrina | May 8, 2025 | News
Carlos Palma worked for years as a manager and Head of Product at the fintech company dLocal, until he decided in 2025 to make a career shift and join B4-RNA as CEO. The startup is one of the ventures supported by LAB+, the company builder of the Institut Pasteur de...
Recent Comments